Geraldine Henwood, President & CEO, Director at Recro Pharma, holds 211.19K shares in Recro Pharma (Ticker: REPH), holds 387.89K shares in Baudax Bio (Ticker: BXRX), holds 0.00 shares in Tetraphase (Ticker: TTPH).
Geraldine Henwood latest transaction was an Uninformative Sell of $657.60K.
What was Geraldine Henwood's most profitable transaction?
Geraldine Henwood’s most profitable transaction was an Informative Sell of ALKS stock on February 23, 2012. The return on the trade was -18.30%.
What is Geraldine Henwood's role in Recro Pharma?
Geraldine Henwood's role in Recro Pharma is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.